Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study - PubMed (original) (raw)

Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study

K A Forde et al. J Viral Hepat. 2012 Apr.

Abstract

Hepatitis C virus (HCV) infection is associated with systemic inflammation and metabolic complications that might predispose patients to atherosclerosis. However, it remains unclear if HCV infection increases the risk of acute myocardial infarction (MI). To determine whether HCV infection is an independent risk factor for acute MI among adults followed in general practices in the United Kingdom (UK), a retrospective cohort study was conducted in The Health Improvement Network, from 1996 through 2008. Patients ≥18 years of age with at least 6 months of follow-up and without a prior history of MI were eligible for study inclusion. HCV-infected individuals, identified with previously validated HCV diagnostic codes (n = 4809), were matched on age, sex and practice with up to 15 randomly selected patients without HCV (n = 71 668). Rates of incident MI among patients with and without a diagnosis of HCV infection were calculated. Adjusted hazard ratios were estimated using Cox proportional hazards regression, controlling for established cardiovascular risk factors. During a median follow-up of 3.2 years, there was no difference in the incidence rates of MI between HCV-infected and -uninfected patients (1.02 vs 0.92 events per 1000 person-years; P = 0.7). HCV infection was not associated with an increased risk of incident MI (adjusted HR, 1.10; 95% confidence interval [CI], 0.67-1.83). Sensitivity analyses including the exploration of a composite outcome of acute MI and coronary interventions yielded similar results (adjusted HR, 1.16; 95% CI, 0.77-1.74). In conclusion, HCV infection was not associated with an increased risk of incident MI.

PubMed Disclaimer

Conflict of interest statement

STATEMENT OF INTERESTS

Declaration of Personal Interests: The authors have no conflicts of interest to disclose.

References

1. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144(10):705–714. - PubMed
1. Balogun MA, Ramsay ME, Hesketh LM, et al. The prevalence of hepatitis C in England and Wales. J Infect. 2002;45(4):219–226. - PubMed
1. Lauer GM, Walker BD. Hepatitis C virus infection. The New England journal of medicine. 2001;345(1):41–52. - PubMed
1. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. The New England journal of medicine. 1999;341(8):556–562. - PubMed
1. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10–12, 2002. Hepatology (Baltimore, Md. 2002;36(5 Suppl 1):S3–S20. - PubMed

Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study - PubMed (original) (raw)